Epigenetic modulation by green tea in prevention of photocarcinogenesis

绿茶的表观遗传调节预防光致癌

基本信息

项目摘要

DESCRIPTION (provided by applicant): Overexposure of the human skin to solar ultraviolet (UV) radiation is the major etiologic factor for the development of melanoma and non-melanoma skin cancers in the United States, with the non-melanoma skin cancer being the most common cutaneous malignancy. Although epigenetic mechanisms have been implicated in UVB-induced skin carcinogenesis, the mechanisms have not been fully characterized. Importantly, epigenetic mechanisms are potentially reversible and represent attractive targets for the prevention of the development of UVB-induced cutaneous malignancies. We have now generated preliminary data that indicate that chronic exposure of the mouse skin to UV radiation induces epigenetic alterations which include: DNA hypermethylation, increases in DNA methyltransferase (Dnmt) activity, and increases in histone de-acetylation and that these alterations may lead to the silencing of tumor suppressor genes in mouse skin. Furthermore, we have made the unique observation that a non-toxic phytochemical may act to prevent photocarcinogenesis through inhibition of epigenetic mechanisms. We had demonstrated previously that administration of green tea polyphenols (GTPs, 0.2%, w/v) in drinking water of mice significantly inhibits UV- induced skin tumor development in terms of tumor incidence (% mice with tumors) and tumor multiplicity. We have now generated preliminary data that suggest that administration of GTPs in drinking water of mice inhibits UVB-induced DNA hypermethylation and Dnmt activity in the skin. Based on our preliminary data, we have formulated the innovative hypothesis that exposure of the skin to UV radiation results in the DNA hypermethylation which leads to epigenetic silencing of key tumor suppressor genes during photocarcinogenesis. We also hypothesize that GTPs prevent UV-induced skin tumor development, at least in part, through the prevention of epigenetic alterations associated with UV radiation. Our long- term goal is to fully test this hypothesis. The objectives of this exploratory R21 application are to verify and extend our preliminary results using the SKH-1 hairless mouse model in order to generate the data necessary for the design of studies that will rigorously test the central hypothesis in mouse and human skin and establish the molecular basis for the observed data. Thus, we propose two complementary Specific Aims: (1) To determine whether inhibition of photocarcinogenesis by GTPs is mediated through inhibition of UVB-induced DNA hypermethylation and Dnmt activity in UVB-exposed skin and tumors, and (2) To determine the molecular mechanisms by which GTPs control epigenetic modulators which regulate key tumor suppressors during photocarcinogenesis. In vitro analyses using human keratinocytes and epigenetic modulating drugs will be used to verify the data generated using the mouse model. The results obtained from this study will generate new knowledge concerning the identity of the epigenetic mechanisms involved in photocarcinogenesis and should indicate whether GTPs exert their skin cancer chemopreventive effects by inhibiting these responses. We address a major public health concern as overexposure of the human skin to solar UV radiation is the major etiologic factor for the development of melanoma and non-melanoma skin cancers in the United States. The proposed studies will provide critical new data concerning UVB-induced carcinogenesis and will identify mechanisms by which green tea may act to prevent/correct UV-induced deficiencies. The development of new strategies using green tea polyphenols as a dietary supplement may help to reduce the risk of skin cancer in humans. There is world-wide interest in green tea as a cancer chemopreventive agent for humans as it is a non-toxic, affordable, popular beverage and is effective in a wide range of organs. PUBLIC HEALTH RELEVANCE: Chronic exposure of the skin to solar ultraviolet (UV) radiation induces multiple adverse effects including the risk of skin cancer development. The epigenetic modifications that occur in DNA play a significant role in the regulation of gene expression and lead to the development of cancers. In the current application, we will determine the molecular mechanism of epigenetic changes which leads to epigenetic silencing of key tumor suppressor genes during photocarcinogenesis. We will also determine whether administration of green tea polyphenols in drinking water of mice prevents photocarcinogenesis in mice through the inhibition of UVB- induced epigenetic alterations and silencing of tumor suppressor genes.
描述(由申请人提供):人体皮肤过度暴露于太阳紫外线(UV)辐射是美国黑色素瘤和非黑色素瘤皮肤癌发展的主要病因,其中非黑色素瘤皮肤癌是最常见的皮肤恶性肿瘤。虽然表观遗传机制已被认为与UVB诱导的皮肤癌有关,但其机制尚未完全确定。重要的是,表观遗传机制可能是可逆的,并且是预防UVB诱导的皮肤恶性肿瘤发展的有吸引力的靶点。我们现在已经产生了初步的数据表明,长期暴露在紫外线辐射下的小鼠皮肤会诱导表观遗传学改变,包括:DNA超甲基化,DNA甲基转移酶(DNMT)活性增加,组蛋白去乙酰化增加,这些改变可能导致小鼠皮肤中肿瘤抑制基因的沉默。此外,我们还观察到一种无毒的植物化学物质可能通过抑制表观遗传机制来预防光癌的发生。我们以前已经证明,在小鼠饮用水中加入绿茶多酚(GTPs,0.2%,w/v)可以显著抑制紫外线诱导的皮肤肿瘤的发生(肿瘤发生率(带瘤鼠的百分比)和肿瘤的多样性)。我们现在已经产生了初步数据,表明在小鼠饮用水中给予GTPS可以抑制UVB诱导的皮肤DNA超甲基化和DNMT活性。基于我们的初步数据,我们提出了一个创新的假设,即皮肤暴露在紫外线辐射下会导致DNA超甲基化,从而导致光致癌过程中关键的肿瘤抑制基因的表观遗传沉默。我们还假设,GTP至少部分地通过防止与紫外线辐射相关的表观遗传学改变来防止紫外线诱导的皮肤肿瘤的发展。我们的长期目标是充分检验这一假设。这一探索性的R21应用程序的目标是使用SKH-1无毛小鼠模型验证和扩展我们的初步结果,以便生成设计研究所需的数据,这些研究将在小鼠和人类皮肤上严格测试中心假设,并为观察到的数据建立分子基础。因此,我们提出了两个互补的特异性目标:(1)确定GTPS对光癌的抑制是否通过抑制UVB诱导的皮肤和肿瘤中的DNA高甲基化和DNMT活性来实现;(2)确定GTPS控制表观遗传调节因子的分子机制,表观遗传调节因子在光致癌过程中调节关键的肿瘤抑制因子。使用人类角质形成细胞和表观遗传调节药物进行的体外分析将用于验证使用小鼠模型产生的数据。这项研究的结果将产生关于光致癌的表观遗传机制的识别的新知识,并应该表明GTP是否通过抑制这些反应来发挥其皮肤癌化学预防作用。我们解决了一个主要的公共卫生问题,因为人类皮肤过度暴露于太阳紫外线辐射是美国黑色素瘤和非黑色素瘤皮肤癌发展的主要病因因素。这项拟议的研究将提供有关UVB诱导致癌的关键新数据,并将确定绿茶预防/纠正UV诱导的缺陷的机制。利用绿茶多酚作为膳食补充剂的新策略的开发可能有助于降低人类患皮肤癌的风险。绿茶是一种无毒、价格实惠、受欢迎的饮料,而且对多种器官有效,因此作为人类癌症化学防御剂的研究受到了全世界的广泛关注。 与公共健康相关:皮肤长期暴露在太阳紫外线(UV)辐射下会导致多种不良影响,包括皮肤癌的风险。DNA中发生的表观遗传修饰在基因表达调控中发挥着重要作用,并导致癌症的发展。在目前的应用中,我们将确定表观遗传变化导致关键抑癌基因在光癌发生过程中表观遗传沉默的分子机制。我们还将确定在小鼠饮用水中加入绿茶多酚是否通过抑制UVB诱导的表观遗传改变和肿瘤抑制基因的沉默来防止小鼠的光癌发生。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling.
  • DOI:
    10.1016/j.taap.2013.09.021
  • 发表时间:
    2013-12-01
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Singh, Tripti;Katiyar, Santosh K.
  • 通讯作者:
    Katiyar, Santosh K.
Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.
癌症化学预防中选定的饮食植物化学物质的表观遗传学调节。
  • DOI:
    10.1016/j.canlet.2014.09.017
  • 发表时间:
    2014-12-01
  • 期刊:
  • 影响因子:
    9.7
  • 作者:
    Shukla, Samriddhi;Meeran, Syed M.;Katiyar, Santosh K.
  • 通讯作者:
    Katiyar, Santosh K.
Hsp90 inhibitor can inhibit UV carcinogenesis.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANTOSH KUMAR KATIYAR其他文献

SANTOSH KUMAR KATIYAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANTOSH KUMAR KATIYAR', 18)}}的其他基金

Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
  • 批准号:
    8883008
  • 财政年份:
    2015
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
  • 批准号:
    9070629
  • 财政年份:
    2015
  • 资助金额:
    $ 15.45万
  • 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
  • 批准号:
    8442533
  • 财政年份:
    2013
  • 资助金额:
    $ 15.45万
  • 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
  • 批准号:
    8601917
  • 财政年份:
    2013
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8431273
  • 财政年份:
    2012
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8698300
  • 财政年份:
    2012
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8240922
  • 财政年份:
    2012
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8803280
  • 财政年份:
    2012
  • 资助金额:
    $ 15.45万
  • 项目类别:
Epigenetic modulation by green tea in prevention of photocarcinogenesis
绿茶的表观遗传调节预防光致癌
  • 批准号:
    7895438
  • 财政年份:
    2010
  • 资助金额:
    $ 15.45万
  • 项目类别:
Prevention of UV-carcinogenesis through DNA repair-dependent immunomodulation
通过 DNA 修复依赖性免疫调节预防紫外线致癌
  • 批准号:
    8210888
  • 财政年份:
    2010
  • 资助金额:
    $ 15.45万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了